2:03 PM ET
10-Q
Financial Results
Guided Therapeutics Q3 2026 Results: Net Loss of $720K, Loss Narrows
Guided Therapeutics reported a net loss of $1.8 million for the nine months ended September 30, 2026, compared to a $2.0 million loss in the prior year period. Revenue decreased significantly to $92,000 from $177,000 year-over-year, while the company continues to operate with a substantial stockholders' deficit of $6.1 million.
- Key figure
- Net loss $720K